PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sector of biopharmaceuticals, featuring promising developments throughout several healthcare and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA gives a safer, additional dependable substitute for therapeutic u